214 related articles for article (PubMed ID: 3131955)
1. Immunohistochemical study of chromogranin in 100 cases of pheochromocytoma, carotid body tumour, medullary thyroid carcinoma and carcinoid tumour.
Kimura N; Sasano N; Yamada R; Satoh J
Virchows Arch A Pathol Anat Histopathol; 1988; 413(1):33-8. PubMed ID: 3131955
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical identification of neuron-specific enolase, synaptophysin, chromogranin and endocrine granule constituent in neuroendocrine tumours.
Vyberg M; Horn T; Francis D; Askaa J
Acta Histochem Suppl; 1990; 38():179-81. PubMed ID: 1964227
[TBL] [Abstract][Full Text] [Related]
3. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
4. Chromogranin A and the alpha-subunit of glycoprotein hormones in medullary thyroid carcinoma and phaeochromocytoma.
Guignat L; Bidart JM; Nocera M; Comoy E; Schlumberger M; Baudin E
Br J Cancer; 2001 Mar; 84(6):808-12. PubMed ID: 11259096
[TBL] [Abstract][Full Text] [Related]
5. A polyclonal antiserum against chromogranin A and B--a new sensitive marker for neuroendocrine tumours.
Eriksson B; Arnberg H; Oberg K; Hellman U; Lundqvist G; Wernstedt C; Wilander E
Acta Endocrinol (Copenh); 1990 Feb; 122(2):145-55. PubMed ID: 2316306
[TBL] [Abstract][Full Text] [Related]
6. Metastatic neuroendocrine tumors to the thyroid gland mimicking medullary carcinoma: a pathologic and immunohistochemical study of six cases.
Matias-Guiu X; LaGuette J; Puras-Gil AM; Rosai J
Am J Surg Pathol; 1997 Jul; 21(7):754-62. PubMed ID: 9236831
[TBL] [Abstract][Full Text] [Related]
7. The occurrence of pancreastatin in tumours of the diffuse neuroendocrine system.
Bishop AE; Bretherton-Watt D; Hamid QA; Fahey M; Shepherd N; Valentino K; Tatemoto K; Ghatei MA; Bloom SR; Polak JM
Mol Cell Probes; 1988 Sep; 2(3):225-35. PubMed ID: 2851738
[TBL] [Abstract][Full Text] [Related]
8. Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours.
Stridsberg M; Oberg K; Li Q; Engström U; Lundqvist G
J Endocrinol; 1995 Jan; 144(1):49-59. PubMed ID: 7891024
[TBL] [Abstract][Full Text] [Related]
9. Peanut lectin: a histochemical marker for phaeochromocytomas.
Moorghen M; Carpenter F
Virchows Arch A Pathol Anat Histopathol; 1991; 419(3):203-7. PubMed ID: 1718080
[TBL] [Abstract][Full Text] [Related]
10. Electron microscopic localization of chromogranin A in osmium-fixed neuroendocrine cells with a protein A-gold technique.
Hearn SA
J Histochem Cytochem; 1987 Jul; 35(7):795-801. PubMed ID: 3295032
[TBL] [Abstract][Full Text] [Related]
11. Chromogranins--new sensitive markers for neuroendocrine tumors.
Eriksson B; Arnberg H; Oberg K; Hellman U; Lundqvist G; Wernstedt C; Wilander E
Acta Oncol; 1989; 28(3):325-9. PubMed ID: 2545231
[TBL] [Abstract][Full Text] [Related]
12. Secretion of chromogranin A by peptide-producing endocrine neoplasms.
O'Connor DT; Deftos LJ
N Engl J Med; 1986 May; 314(18):1145-51. PubMed ID: 3007986
[TBL] [Abstract][Full Text] [Related]
13. Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours.
Nilsson O; Wängberg B; Kölby L; Schultz GS; Ahlman H
Int J Cancer; 1995 Mar; 60(5):645-51. PubMed ID: 7860139
[TBL] [Abstract][Full Text] [Related]
14. Chromogranin A as a marker of neuroendocrine histogenesis of tumours: an immunoelectron microscopic study with considerations about the influence of fixation and embedding media on immunolabelling.
Leone BE; Taccagni GL; Dell'Antonio G; Cantaboni A
Basic Appl Histochem; 1990; 34(2):143-53. PubMed ID: 2222401
[TBL] [Abstract][Full Text] [Related]
15. Synaptophysin immunoreactivity and small clear vesicles in neuroendocrine cells and related tumours.
Buffa R; Rindi G; Sessa F; Gini A; Capella C; Jahn R; Navone F; De Camilli P; Solcia E
Mol Cell Probes; 1987 Dec; 1(4):367-81. PubMed ID: 3134611
[TBL] [Abstract][Full Text] [Related]
16. Chromogranin A in human neuroendocrine tumors: an immunohistochemical study with region-specific antibodies.
Portel-Gomes GM; Grimelius L; Johansson H; Wilander E; Stridsberg M
Am J Surg Pathol; 2001 Oct; 25(10):1261-7. PubMed ID: 11688460
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of somatostatin type 2A receptor in neuroendocrine tumors.
Kimura N; Pilichowska M; Date F; Kimura I; Schindler M
Clin Cancer Res; 1999 Nov; 5(11):3483-7. PubMed ID: 10589762
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine markers and sustentacular cell count in benign and malignant pheochromocytomas - a comparative study.
Białas M; Okoń K; Dyduch G; Ciesielska-Milian K; Buziak M; Hubalewska-Dydejczyk A; Sobrinho-Simoes M
Pol J Pathol; 2013 Jun; 64(2):129-35. PubMed ID: 23900871
[TBL] [Abstract][Full Text] [Related]
19. Immunoreactivity to chromogranin and to vasoactive intestinal peptide in a canine phaeochromocytoma.
Cuervo L; Balaguer L; Romano J; Idigoras I; Gonzalez L
J Comp Pathol; 1994 Oct; 111(3):327-31. PubMed ID: 7836575
[TBL] [Abstract][Full Text] [Related]
20. Chromogranin A, B and C immunoreactivities of mammalian endocrine cells. Distribution, distinction from costored hormones/prohormones and relationship with the argyrophil component of secretory granules.
Rindi G; Buffa R; Sessa F; Tortora O; Solcia E
Histochemistry; 1986; 85(1):19-28. PubMed ID: 3525472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
